The results showed that TNF-α treatment enhanced cell viability and increased GSH levels while reducing the sensitivity of CRC cells to RSL3-induced ferroptosis (Fig. 7B–D and Fig. S6D). The gene discussed is TNF; the disease is colorectal carcinoma.